Loading...
XNAS
HSIC
Market cap8.94bUSD
Jul 11, Last price  
73.42USD
1D
-1.49%
1Q
13.90%
Jan 2017
-3.22%
Name

Henry Schein Inc

Chart & Performance

D1W1MN
P/E
22.91
P/S
0.71
EPS
3.20
Div Yield, %
Shrs. gr., 5y
-3.06%
Rev. gr., 5y
4.88%
Revenues
12.67b
+2.71%
4,635,929,0005,153,097,0005,920,190,0006,394,874,0006,538,336,0007,526,790,0008,530,242,0008,939,967,0009,560,647,00010,371,390,00010,629,719,00011,571,668,00012,461,543,00013,201,995,0009,985,803,00010,119,141,00012,401,021,00012,647,000,00012,339,000,00012,673,000,000
Net income
390m
-6.25%
151,326,000163,759,000215,173,000243,143,000311,153,000325,789,000367,661,000388,076,000431,554,000466,077,000479,058,000506,778,000406,299,000535,881,000520,792,000403,794,000631,000,000538,000,000416,000,000390,000,000
CFO
848m
+69.60%
265,141,000235,317,000270,211,000384,649,000396,890,000388,874,000554,625,000408,099,000664,175,000592,504,000586,841,000615,461,000545,515,000684,706,000654,087,000598,910,000709,580,000602,000,000500,000,000848,000,000
Earnings
Aug 04, 2025

Profile

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
IPO date
Nov 03, 1995
Employees
23,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
12,673,000
2.71%
12,339,000
-2.44%
12,647,000
1.98%
Cost of revenue
8,657,000
8,478,000
8,816,000
Unusual Expense (Income)
NOPBT
4,016,000
3,861,000
3,831,000
NOPBT Margin
31.69%
31.29%
30.29%
Operating Taxes
128,000
120,000
170,000
Tax Rate
3.19%
3.11%
4.44%
NOPAT
3,888,000
3,741,000
3,661,000
Net income
390,000
-6.25%
416,000
-22.68%
538,000
-14.74%
Dividends
Dividend yield
Proceeds from repurchase of equity
(385,000)
(250,000)
(515,000)
BB yield
4.28%
2.51%
4.68%
Debt
Debt current
781,000
490,000
182,000
Long-term debt
2,423,000
2,637,000
1,663,000
Deferred revenue
9,000
8,000
Other long-term liabilities
387,000
427,000
353,000
Net debt
2,912,000
2,732,000
1,567,000
Cash flow
Cash from operating activities
848,000
500,000
602,000
CAPEX
(148,000)
(147,000)
(96,000)
Cash from investing activities
(430,000)
(1,135,000)
(276,000)
Cash from financing activities
(510,000)
701,000
(315,000)
FCF
4,170,000
3,153,000
3,413,525
Balance
Cash
122,000
171,000
117,000
Long term investments
170,000
224,000
161,000
Excess cash
Stockholders' equity
4,837,000
5,153,000
4,671,000
Invested Capital
8,094,000
8,326,000
6,397,000
ROIC
47.36%
50.82%
58.44%
ROCE
49.00%
46.07%
59.55%
EV
Common stock shares outstanding
127,779
131,748
137,756
Price
70.42
-6.99%
75.71
-5.21%
79.87
6.59%
Market cap
8,998,213
-9.79%
9,974,654
-9.34%
11,002,545
3.57%
EV
13,354,213
14,204,654
13,794,545
EBITDA
4,313,000
4,109,000
4,043,000
EV/EBITDA
3.10
3.46
3.41
Interest
131,000
87,000
44,000
Interest/NOPBT
3.26%
2.25%
1.15%